2020
DOI: 10.1111/are.14690
|View full text |Cite
|
Sign up to set email alerts
|

Prokaryotic expression of a hub protein of white spot syndrome virus with vaccine potential

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Prokaryotic protein expression systems are usually the first choice for protein heterologous expression because of their obvious advantages. For example, the envelope protein VP62 of the white spot syndrome virus, a protein with vaccine potential, was expressed and purified in E. coli (Lu et al 2020). The novel antibacterial fusion protein cecropin B-human lysozyme was also expressed in E. coli (Zhang et al 2019).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Prokaryotic protein expression systems are usually the first choice for protein heterologous expression because of their obvious advantages. For example, the envelope protein VP62 of the white spot syndrome virus, a protein with vaccine potential, was expressed and purified in E. coli (Lu et al 2020). The novel antibacterial fusion protein cecropin B-human lysozyme was also expressed in E. coli (Zhang et al 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Some inclusion bodies can become soluble proteins by altering the expression vectors or by changing the culture conditions such as culture temperature, IPTG concentration and induction times. However, other inclusion bodies remain insoluble proteins regardless of alterations to the expression vectors or culture conditions (Makrides 1996;Rabhi-Essafi et al 2017;Lu et al 2020). It is highly likely that the insolubility may be related to the lack of a post-translational modification mechanism and/or the lack of respective chaperon proteins for the target protein in the heterologous prokaryotic expression host E. coli (Sui et al 2018).…”
Section: Discussionmentioning
confidence: 99%